笛卡爾物流系統集團 DSGX 深 滬
等待開盤 02-10 09:30:00 美东时间
67.41
+0.630
+0.94%
華盛通- 最 高67.83
- 今 開66.89
- 成交量 69.19万股
- 最 低 65.94
- 昨 收 66.78
- 總市值 57.96亿
- 52周最高 117.35
- 市盈率 靜 41.09
- 換手率 0.80%
- 52周最低 64.27
- 委 比 83.29%
- 總股本 8598.68万
- 歷史最高 124.31
- 量 比 0.56
- 振 幅 2.83%
- 歷史最低 5.71
- 每 手 1
- 風險率 10.60%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Descartes Brings AI-Powered Logistics and Automation Tools to Manifest 2026
Descartes Systems Group (NASDAQ:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, is showcasing its latest technology innovations focused on artificial intelligence (AI) and
02-09 19:56
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
Scotiabank Maintains Sector Outperform on Descartes Systems Group, Lowers Price Target to $95
Scotiabank analyst Kevin Krishnaratne maintains Descartes Systems Group (NASDAQ:DSGX) with a Sector Outperform and lowers the price target from $115 to $95.
02-04 23:15
2026年美股软件股将逆袭！巴克莱力挺：AI变现助力估值重塑 优选赛富时、甲骨文、DigitalOcean
巴克莱认为，2026年美股软件股前景向好。宏观经济和IT支出稳定、估值水平处于低位，且该板块目前不受市场青睐。
01-13 15:53
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Barclays Upgrades Descartes Systems Group to Overweight, Lowers Price Target to $105
Barclays analyst Raimo Lenschow upgrades Descartes Systems Group (NASDAQ:DSGX) from Equal-Weight to Overweight and lowers the price target from $106 to $105.
01-12 20:46
Descartes Systems Group Posts Record Results, Eyes AI-Led Growth
The Descartes Systems Group Inc. (($TSE:DSG)) has held its Q3 earnings call. Re...
2025-12-24 08:00
受关税影响，美国最大港口11月进口量同比下降11.5%
美国最大港口洛杉矶港的执行董事Gene Seroka周二表示，该港口11月份的进口量较上年同期减少11.5%，原因是托运人提前建立了库存，以避免美国总统特朗...
2025-12-17 07:17
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
Descartes Announces TSX Acceptance of Normal Course Issuer Bid
Descartes Systems Group Inc. announced it has received Toronto Stock Exchange (TSX) approval to launch a Normal Course Issuer Bid (NCIB) to repurchase up to 8,568,582 common shares, representing approximately 10% of its public float, on or before December 10, 2026. Repurchases will be made in the open market at management's discretion, subject to TSX rules. The maximum daily purchase limit on the TSX is 51,176 shares, excluding block purchases. F...
2025-12-09 11:45
